Leucovorin prescriptions for children rise 46% after federal officials' autism claims
Medical Xpress
A study reveals that leucovorin prescriptions for children surged by 46 percent following controversial claims made by federal officials regarding its potential benefits for autism. This dramatic increase highlights the significant impact of official statements on prescribing behaviors despite limited scientific evidence supporting the treatment. The finding underscores concerns about the rapid adoption of unproven medical interventions driven by public health announcements.
All articles from 13 August 2026. Summaries are AI-generated and may contain errors; the linked article is the authority.